IMU 0.00% 4.5¢ imugene limited

Why IMU is a multi multi bagger, page-16656

  1. 297 Posts.
    lightbulb Created with Sketch. 249
    Hi Taureanbull, thank you for your kind words and feedback.

    Experience has just come from exposure across a number of biotech stocks and the love of learning about the sector. I am definitely not an expert and still have a lot to learn. Somehow my portfolio became heavily waited in the biotech sector, probably because I find it is one of the most exciting and mentally stimulating sectors to be involved with on the ASX. The companies have a purpose, the science is fascinating, and it really can change lives for both patients and investors.

    It is also one of the sectors where I think you can find companies that fit the well documented and successful criteria models of great investors such as Benjamin Graham and Warren Buffett. I know they would never invest in biotech because of the risk factor, however I believe that most of the other criteria is there if you go looking, such as….Is there a need and a market for the product. Is it an exclusive or sizeable market, look for first in class or orphan drug designation. Extreme value buying where the SP just doesn’t represent the value of the company, intellectual property or forward earning potential, significant future SP upside. Protection of market position with long patents. Great management capability, have they done this before and been successful.

    So I think you need to be able to do three things, be able to find companies that have the above attributes, have a long term investment strategy where the SP will align with true value over time and how to manage your risk.

    The first two are fairly straight forward and just involve time. For risk I believe that can be managed by diversifying your biotech portfolio. Given statistically it is only about 1 in 8 that are successful, you need to play the odds in your portfolio and find around 8 to 12 biotech companies that have the previous mentioned attributes with a high reward factor. If you can do this I think you can stack the odds in your favour.

    I like IMU for the above reasons and more so as they are well diversified in their own right with multiple assets.

    If you don’t mind taking on risk, don’t get to emotionally caught up and have realistic expectations I think biotech is a great place to be.

    These are just my thoughts and strategies that I apply towards the biotech sector and shouldn’t be considered as advice but things to think about.
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
4.5¢
Change
0.000(0.00%)
Mkt cap ! $334.7M
Open High Low Value Volume
4.6¢ 4.6¢ 4.4¢ $417.0K 9.281M

Buyers (Bids)

No. Vol. Price($)
37 6074903 4.4¢
 

Sellers (Offers)

Price($) Vol. No.
4.5¢ 362283 5
View Market Depth
Last trade - 16.10pm 07/11/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.